Moderna Inc
NASDAQ:MRNA

Watchlist Manager
Moderna Inc Logo
Moderna Inc
NASDAQ:MRNA
Watchlist
Price: 33.8 USD 9.21% Market Closed
Market Cap: 13.2B USD

Wall Street
Price Targets

MRNA Price Targets Summary
Moderna Inc

Wall Street analysts forecast MRNA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MRNA is 38.07 USD with a low forecast of 17.17 USD and a high forecast of 141.75 USD.

Lowest
Price Target
17.17 USD
49% Downside
Average
Price Target
38.07 USD
13% Upside
Highest
Price Target
141.75 USD
319% Upside
Moderna Inc Competitors:
Price Targets
301047
Sino Biological Inc
19% Upside
EXAS
Exact Sciences Corp
1% Downside
214450
PharmaResearch Co Ltd
100% Upside
2162
KeyMed Biosciences Inc
53% Upside
1530
3SBio Inc
47% Upside
688428
InnoCare Pharma Ltd
78% Upside
ORY
Oryzon Genomics SA
146% Upside
302440
SK Bioscience Co Ltd
23% Downside

Revenue
Forecast

Revenue Estimate
Moderna Inc

For the last 7 years the compound annual growth rate for Moderna Inc's revenue is 48%. The projected CAGR for the next 4 years is 0%.

48%
Past Growth
0%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Moderna Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Moderna Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MRNA's stock price target?
Price Target
38.07 USD

According to Wall Street analysts, the average 1-year price target for MRNA is 38.07 USD with a low forecast of 17.17 USD and a high forecast of 141.75 USD.

What is Moderna Inc's Revenue forecast?
Projected CAGR
0%

For the last 7 years the compound annual growth rate for Moderna Inc's revenue is 48%. The projected CAGR for the next 4 years is 0%.

Back to Top